Bill Search

  • Introduced
    Jan 26, 2024
  • Passed House
  • Passed Senate
  • Signed into Law
HB 2222
Tennessee House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
DNA and Genetic Testing - As enacted, requires the department of health to conduct a review and issue a report to the general assembly on variants of the apolipoprotein L1 (APOL1) gene associated with increased risk of end-stage renal disease. - Amends TCA Title 68, Chapter 5.
Last Action See all actions
executive • May 09, 2024: Comp. became Pub. Ch. 838
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on HB 2222

Tweets

Whip Lists

Sponsors
Votes
Actions
  • May 09, 2024 | executive
    • Comp. became Pub. Ch. 838
  • Apr 18, 2024 | House
    • Comp. SB subst.
    • Sponsor(s) Added.
  • Apr 16, 2024 | House
    • Sponsor(s) Added.
  • Apr 11, 2024 | House
    • H. Placed on Regular Calendar for 4/16/2024
  • Apr 10, 2024 | House
    • Placed on cal. Calendar & Rules Committee for 4/11/2024
  • Apr 03, 2024 | House
    • Sponsor(s) Added.
    • Rec. for pass. if am., ref. to Calendar & Rules Committee
  • Mar 27, 2024 | House
    • Placed on cal. Health Committee for 4/3/2024
  • Mar 26, 2024 | House
    • Rec for pass if am by s/c ref. to Health Committee
  • Mar 20, 2024 | House
    • Action Def. in s/c Health Subcommittee to 3/26/2024
    • Placed on s/c cal Health Subcommittee for 3/26/2024
  • Mar 13, 2024 | House
    • Placed on s/c cal Health Subcommittee for 3/19/2024
  • Jan 31, 2024 | House
    • P2C, ref. to Health Committee
    • Assigned to s/c Health Subcommittee
  • Jan 29, 2024 | House
    • Intro., P1C.
  • Jan 26, 2024 | House
    • Filed for introduction